Citigroup
PAVM icon

Citigroup’s PAVmed PAVM Stock Holding History

Citigroup’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$16 – 6350
2025
Q3 		$16 Buy
+1
New +$15 ﹤0.01% 5914
2022
Q3 		– Sell
-16
Closed -$7K – 6201
2022
Q2 		$7K Sell
16
-1
-6% -$483 ﹤0.01% 5507
2022
Q1 		$10K Sell
17
-23
-58% -$17.1K ﹤0.01% 5540
2021
Q4 		$45K Buy
40
+22
+122% +$47.8K ﹤0.01% 5118
2021
Q3 		$68K Buy
18
+7
+64% +$22.1K ﹤0.01% 4580
2021
Q2 		$32K Buy
11
+1
+10% +$2.36K ﹤0.01% 5049
2021
Q1 		$21K Sell
10
-6
-38% -$9.02K ﹤0.01% 5230
2020
Q4 		$15K Buy
16
+12
+300% +$10.3K ﹤0.01% 6798
2020
Q3 		$3K Sell
4
-10
-71% -$8.9K ﹤0.01% 7223
2020
Q2 		$14K Buy
+14
New +$14K ﹤0.01% 6865

Other funds holding PAVM

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup's PAVM Position: Q4 2025 in Review

Citigroup sold out of PAVmed (PAVM) in Q4 2025, closing a stake of 1 share — an estimated $16 sold.

Citigroup first reported a position in PAVM in Q2 2020 and held it in 10 quarters. The position peaked at $68K in Q3 2021. 28 funds tracked by Wall St. Rank hold PAVM as of Q4 2025.

  • Citigroup reported no remaining PAVmed position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 1 PAVmed share in Q4 2025, an estimated $16.
  • Citigroup first reported a position in PAVmed in Q2 2020 and held it in 10 quarters.
  • Citigroup's PAVmed position peaked at $68K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held PAVmed as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.